FDA inspection
Sinsin Pharmaceutical Co., Ltd.: FDA inspection ending Dec 13, 2019
FDA inspection 1112744 · Voluntary Action Indicated (VAI) · Sejong
Key facts
| Inspection ID | 1112744 |
|---|---|
| Firm | Sinsin Pharmaceutical Co., Ltd. |
| FEI number | 3002277609 |
| Address | 141 Beon-Gil, Danwon |
| City | Sejong |
| Country | Korea (the Republic of) |
| Fiscal year | 2020 |
| Inspection end date | Dec 13, 2019 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data